Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K4OF
|
|||
| Former ID |
DIB009142
|
|||
| Drug Name |
PlaMavax
|
|||
| Synonyms |
AdCh63-ME-TRAP; MVA-ME-TRAP; ME-TRAP fusion antigen adenoviral vector vaccine (Malaria), Okairos
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 2 | [1] | |
| Company |
University of Oxford
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Plasmodium Thrombospondin relate anonymous protein (Plasm TRAP) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01658696) Efficacy of Candidate Malaria Vaccines in Senegalese Adults. U.S. National Institutes of Health. | |||
| REF 2 | Lipid kinase enters the malaria stage. SciBX 6(48); doi:10.1038/scibx.2013.1373. Dec. 19 2013 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.